Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thüringen)

Area of Science:

• Epidemiology
• Neurology
• Genetics

Background:

• Werdnig-Hoffmann disease, also known as acute infantile spinal muscular atrophy (ASMA), is a severe genetic neuromuscular disorder.
• Previous studies suggested potential regional variations in ASMA frequency, particularly between Western and Central/Eastern Europe.

Purpose of the Study:

• To determine the incidence and prevalence of ASMA in West-Thüringen, Germany.
• To assess if the observed incidence aligns with or challenges existing epidemiological data for ASMA.
• To explore potential factors contributing to the observed disease rates in the studied region.

Main Methods:

• Epidemiological analysis of the largest dataset on ASMA in West-Thüringen.
• Calculation of ASMA incidence based on live births.
• Calculation of ASMA prevalence within the general population as of a specific date.

Main Results:

• The incidence of ASMA was found to be 1 in 10,202 live births.
• The prevalence of ASMA in the general population was 1 in 595,362 as of December 31, 1987.
• The study revealed a higher-than-expected incidence rate for ASMA in West-Thüringen.

Conclusions:

• The high incidence rate of ASMA in West-Thüringen supports the hypothesis that ASMA may be more frequent in Central and Eastern Europe compared to Western Europe.
• The comprehensive ascertainment of cases, facilitated by a well-organized and centralized healthcare system in Thüringen, is considered a primary factor for the high observed incidence rate.
• This study underscores the importance of robust healthcare infrastructure in accurate epidemiological assessments of rare diseases.